Skip to main content

Table 4 Expected Incidence of Contralateral Breast Cancer (CBC) by Degree of Family History of Breast Cancer

From: Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033)

Patient and Disease Characteristics

No. of CBCs/1000 women over 10 years

No Family History

Breast Cancer in a Second-Degree Relative

Breast Cancer in a First-Degree Relative

Unilateral

Bilateral

Age (years)

ER Status

Stage

No CPM

CPM

Δ

No CPM

CPM

Δ

No CPM

CPM

Δ

No CPM

CPM

Δ

40

Positive

I

46

2

44

59

3

56

86

4

82

158

9

149

40

Negative

I

58

3

55

74

4

70

108

6

102

193

10

183

40

Positive

II

41

2

39

52

3

49

77

4

73

137

8

129

40

Negative

II

49

2

47

64

3

61

93

5

88

169

9

160

40

Positive

III

29

2

27

36

2

34

54

3

51

98

5

93

40

Negative

III

36

2

34

46

2

44

67

3

64

121

7

114

50

Positive

I

46

2

44

59

3

56

86

5

81

154

8

146

50

Negative

I

57

3

54

73

4

69

107

6

101

191

11

180

50

Positive

II

40

2

38

51

2

49

75

3

72

134

7

127

50

Negative

II

49

2

47

63

3

60

92

5

87

166

9

157

50

Positive

III

28

1

27

36

2

34

53

3

50

95

5

90

50

Negative

III

35

2

33

45

2

43

66

3

63

119

6

113

60

Positive

I

45

2

43

57

3

54

83

4

79

152

8

144

60

Negative

I

54

3

51

70

4

66

102

5

97

183

10

173

60

Positive

II

38

2

36

49

2

47

72

4

68

132

7

125

60

Negative

II

49

3

46

62

3

59

90

5

85

163

9

154

60

Positive

III

28

1

27

36

2

34

53

3

50

95

5

90

60

Negative

III

35

2

33

45

2

43

66

3

63

117

6

111

70

Positive

I

41

2

39

53

3

50

77

4

73

141

8

133

70

Negative

I

52

3

49

66

3

63

96

5

91

173

9

164

70

Positive

II

36

2

34

47

3

44

68

4

64

121

7

114

70

Negative

II

45

2

43

57

3

54

83

4

79

150

8

142

70

Positive

III

26

1

25

34

1

33

50

2

48

89

4

85

70

Negative

III

32

2

30

41

2

39

59

3

56

108

6

102

  1. ER estrogen receptor, CPM contralateral prophylactic mastectomy, Δ, difference (No CPM-CPM); CBC risk reduction = 95% (base-case)